Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
GLP-1 Receptor Agonist Market Restraints The key restraints on the GLP-1 receptor agonist market include: High Drug Costs Compared To Standard Diabetes Or Obesity Therapy High drug costs compared to standard diabetes or obesity therapy are restricting the growth of the GLP-1 receptor agonist market during the forecast period
Novo Nordisk reported over $24.5 billion in sales in the first nine months of 2023, and more than one third of that is attributed to Ozempic
Consult withour healthcare professional to see how our injections can fit into your wellness routine
Nausea typically emerges first, often appearing within 24 hours as your body adjusts to the medication's mechanism
)
A., & Girardi, A
US$ 21.19
US$ 23.15
US$ 29.33
US$ 29.19
US$ 25.37
US$ 27.25
US$ 28.76
